Christopher Van Tuyl serves as the Chief Legal Officer and Corporate Secretary at Immunovant Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune diseases. With over 20 years of experience in corporate law and regulatory affairs, Van Tuyl has established himself as a key leader in the life sciences sector. He earned his Juris Doctor from Harvard Law School and began his career at a prestigious international law firm, where he specialized in mergers and acquisitions, intellectual property, and compliance matters. Prior to joining Immun